Scholar Rock Drug Wins First-in-Class Approval in Rare Neuromuscular Disease
Scholar Rock’s Isembyld isn’t the only FDA-approved therapy for spinal muscular atrophy, but it is…
Scholar Rock’s Isembyld isn’t the only FDA-approved therapy for spinal muscular atrophy, but it is the first one that directly targets muscle tissue. Isembyld is the first commercial product for Scholar Rock, which is also evaluating the antibody in other rare muscle disorders. The post Scholar Rock Drug Wins First-in-Class Approval in Rare Neuromuscular Disease…
If trust, transparency, and accountability remain core values in medicine, AI governance cannot be left to improvisation. The post Shadow AI Is the Fastest Growing Force in Medicine, and Hospitals Are the Only Ones Who Can Control It appeared first on MedCity News.
This webinar explores how healthcare organizations can leverage AI not just for efficiency but to foster genuine patient engagement and strengthen human connections, emphasizing the importance of patient-centered care.
Corrections can improve the accuracy of people’s beliefs, but their impact may depend on reaching people before a claim has already spread widely. And research on AI-generated search results suggests that people may be less likely to visit the original sources behind AI-generated answers.
[Sponsored] A new Experian playbook shows what privacy-first activation looks like in practice, from governed onboarding through partner-enabled measurement. The post From Onboarding to Outcomes: The Privacy-First Identity Workflow for Pharma Marketing appeared first on MedCity News.
The little girl stared up at Norma Gómez from the doorway of her neighbor’s apartment, her sad, brown eyes suddenly flashing with hope. “Are you the person who’s going to bring my mom back?” she asked. Gómez struggled to find an answer. It was a December morning, and she’d brought food, diapers, baby wipes, and…
Some states expect HIEs to create centralized telehealth infrastructure, develop AI search tools
Interra Health is helping Medicare patients access $50-per-month GLP-1s through the new Bridge program. The post Interra Health Adds GLP-1 Bridge Program Support appeared first on MedCity News.
By EMANUEL SARKEES Most people assume that when they need a doctor, a doctor will be available. That assumption is getting harder to hold onto. Right now, more than 83 million Americans live in highlighted Health Professional Shortage Areas, which is the government’s official notice that where they live does not have enough physicians to…
Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView Capital. The platform uses ambient sensors and computer vision to predict falls before they happen. The post Inspiren Rakes In $70M to Scale Its AI-Powered Senior Living Platform appeared first on MedCity News.